Search results
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 4 days agoEli Lilly became the most valuable health-care company in the world on the back of its blockbuster...
Teladoc Health BrandVoice: GLP-1 End Game: Should Deprescribing Be The Goal?
Forbes· 2 days agoThe early stages of any new, clinically impactful drug put pressure on benefit leaders. While...
Doctors couldn’t help. They turned to a shadow system of DIY medical tests.
Anchorage Daily News· 6 days agoAngelika Sharma was desperate. Half a dozen pediatric specialists largely dismissed her daughter’s...
UC Irvine researchers project cardiac benefits from weight-loss medication tirzepatide
UC Irvine Today· 6 days agoNew study finds that popular weight-loss medication may reduce the number of U.S. adults with ...
Guidelines outline nutrition requirements for those on Ozempic, Wegovy, Zepbound
UPI· 4 days agoFolks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements...
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 4 days agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50...
Eli Lilly stock hits all-time high: What’s been driving the pharma giant’s share price higher?
AOL· 3 days agoEli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive developments for the pharmaceutical ...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 4 days agoWith its stock price fast approaching $1000 per share, drugmaker Eli lilly is poised for a forward...
Scams tied to Ozempic and other new weight-loss drugs are surging. How to protect yourself
Los Angeles Times· 3 days agoOzempic, Wegovy and other new weight-loss drugs have proved so good at helping users shed pounds,...
Biohaven Ltd. (NYSE:BHVN) Given Average Recommendation of “Buy” by Brokerages
ETF DAILY NEWS· 6 days agoShares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the company, Marketbeat reports. TD Cowen raised ...